Paired-box gene 2 is down-regulated in endometriosis and correlates with low epidermal growth factor receptor expression

Human Reproduction

Volumn 27, Issue 6, 2012, Pages 1676-1684

  De Graaff, A A ^a,b   Delvoux, B ^a,b   Van De Vijver, K K ^a,b,d   Kyama, C M ^c   Dhooghe, T M ^c   Dunselman, G A J ^a,b   Romano, A ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

CpG methylation; Endometriosis; Epidermal growth factor; Estrogen; Paired box 2; Progesterone

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; MESSENGER RNA; PROGESTERONE; RNA; TRANSCRIPTION FACTOR PAX2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84858724823     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/des124     Document Type: Article

References (31)

1. Akaike H, Petrov B, Csàki F. Information theory and an extension of the maximum likelihood principle. In: Second International Symposium of Inference Theory. Akadémiai Kiadó, Budapest, 1973,67-281.
2. Borghese B, Barbaux S, Mondon F, Santulli P, Pierre G, Vinci G, Chapron C, Vaiman D. Research resource: genome-wide profiling of methylated promoters in endometriosis reveals a subtelomeric location of hypermethylation. Mol Endocrinol 2010;24:1872-1885.
3. Bose SK, GibsonW, Giri S, Nath N, Donald CD. Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor. Prostate 2009;69:1334-1342.
4. Burney RO, Hamilton AE, Aghajanova L, Vo KC, Nezhat CN, Lessey BA, Giudice LC. MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis. Mol Hum Reprod 2009;15:625-631.
5. Chi N, Epstein JA. Getting your Pax straight: Pax proteins in development and disease. Trends Genet 2002;18:41-47.
6. Dahl E, Koseki H, Balling R. Pax genes and organogenesis. Bioessays 1997; 19:755-765.
7. Dassen H, Punyadeera C, Kamps R, Delvoux B, Van Langendonckt A, Donnez J, Husen B, Thole H, Dunselman G, Groothuis P. Estrogen metabolizing enzymes in endometrium and endometriosis. Hum Reprod 2007;22:3148-3158.
8. Dassen H, Punyadeera C, Delvoux B, Schulkens I, Marchetti C, Kamps R, Klomp J, Dijcks F, de Goeij A, D'Hooghe T et al. Olfactomedin-4 regulation by estrogen in the human endometrium requires epidermal growth factor signaling. Am J Pathol 2010;177:2495-2508.
9. Delvoux B, Groothuis P, D'Hooghe T, Kyama C, Dunselman G, Romano A. Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism. J Clin Endocrinol Metab 2009;94:876-883.
10. Eccles MR. The role of PAX2 in normal and abnormal development of the urinary tract. Pediatr Nephrol 1998;12:712-720.
11. Frost V, Grocott T, Eccles MR, Chantry A. Self-regulated Pax gene expression and modulation by the TGFbeta superfamily. Crit Rev Biochem Mol Biol 2008;43:371-391.
12. Fujii S. Secondary Mullerian system and endometriosis. Am J Obstet Gynecol 1991;165:219-225.
13. Guo SW, Wang Y. Sources of heterogeneities in estimating the prevalence of endometriosis in infertile and previously fertile women. Fertil Steril 2006;86:1584-1595.
14. Liu S, Cieslinski DA, Funke AJ, Humes HD. Transforming growth factor-beta 1 regulates the expression of Pax-2, a developmental control gene, in renal tubule cells. Exp Nephrol 1997;5:295-300.
15. Luu VD, Boysen G, Struckmann K, Casagrande S, von Teichman A, Wild PJ, Sulser T, Schraml P, Moch H. Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma. Clin Cancer Res 2009;15:3297-3304.
16. Merrill JA. Spontaneous endometriosis in the Kenya baboon (Papio doguera). Am J Obstet Gynecol 1968;101:569-570.
17. Monte NM, Webster KA, Neuberg D, Dressler GR, Mutter GL. Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer. Cancer Res 2010;70:6225-6232.
18. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol 1975;122:262-263.
19. Ohtake H, Katabuchi H, Matsuura K, Okamura H. A novel in vitro experimental model for ovarian endometriosis: the three-dimensional culture of human ovarian surface epithelial cells in collagen gels. Fertil Steril 1999;71:50-55.
20. Rabban JT, McAlhany S, Lerwill MF, Grenert JP, Zaloudek CJ. PAX2 distinguishes benign mesonephric and Mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma. Am J Surg Pathol 2010;34:137-146.
21. Romano A, Delvoux B, Fischer DC, Groothuis P. The PROGINS polymorphism of the human progesterone receptor diminishes the response to progesterone. J Mol Endocrinol 2007;38:331-350.
22. Sampson J. The development of the implantation theory for the origin of peritoneal endometriosis. Am J Obstet Gynecol 1940;40: 549-557.
23. Strissel PL, Ellmann S, Loprich E, Thiel F, Fasching PA, Stiegler E, Hartmann A, Beckmann MW, Strick R. Early aberrant insulin-like growth factor signaling in the progression to endometrial carcinoma is augmented by tamoxifen. Int J Cancer 2008;123:2871-2879.
24. Suginami H. A reappraisal of the coelomic metaplasia theory by reviewing endometriosis occurring in unusual sites and instances. Am J Obstet Gynecol 1991;165:214-218.
25. Tong GX, Chiriboga L, Hamele-Bena D, Borczuk AC. Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Mullerian system origin? Mod Pathol 2007;20:856-863.
26. Torres M, Gomez-Pardo E, Dressler GR, Gruss P. Pax-2 controls multiple steps of urogenital development. Development 1995;121:4057-4065.
27. Tung CS, Mok SC, Tsang YT, Zu Z, Song H, Liu J, Deavers MT, Malpica A, Wolf JK, Lu KH et al. PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas. Mod Pathol 2009;22:1243-1250.
28. Uzan C, Darai E, Valent A, Graesslin O, Cortez A, Rouzier R, Vielh P. Status of HER1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma. Virchows Arch 2009;454:525-529.
29. van Kaam KJ, Delvoux B, Romano A, D'Hooghe T, Dunselman GA, Groothuis PG. Deoxyribonucleic acid methyltransferases and methyl-CpG-binding domain proteins in human endometrium and endometriosis. Fertil Steril 2011;95:1421-1427.
30. Wu H, Chen Y, Liang J, Shi B,Wu G, Zhang Y, Wang D, Li R, Yi X, Zhang H et al. Hypomethylation-linked activation of PAX2 mediates tamoxifenstimulated endometrial carcinogenesis. Nature 2005;438:981-987.
31. Zhang H, Zhao X, Liu S, Li J, Wen Z, Li M. 17betaE2 promotes cell proliferation in endometriosis by decreasing PTEN via NFkappaB-dependent pathway. Mol Cell Endocrinol 2010;317:31-43.